Shakinah, S.; Aini, M.H.; Sekartini, R.; Soedjatmiko; Medise, B.E.; Gunardi, H.; Yuniar, I.; Indawati, W.; Koesnoe, S.; Harimurti, K.;
et al. Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in Indonesia. Vaccines 2024, 12, 371.
https://doi.org/10.3390/vaccines12040371
AMA Style
Shakinah S, Aini MH, Sekartini R, Soedjatmiko, Medise BE, Gunardi H, Yuniar I, Indawati W, Koesnoe S, Harimurti K,
et al. Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in Indonesia. Vaccines. 2024; 12(4):371.
https://doi.org/10.3390/vaccines12040371
Chicago/Turabian Style
Shakinah, Sharifah, Muhammad Hafiz Aini, Rini Sekartini, Soedjatmiko, Bernie Endyarni Medise, Hartono Gunardi, Irene Yuniar, Wahyuni Indawati, Sukamto Koesnoe, Kuntjoro Harimurti,
and et al. 2024. "Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in Indonesia" Vaccines 12, no. 4: 371.
https://doi.org/10.3390/vaccines12040371
APA Style
Shakinah, S., Aini, M. H., Sekartini, R., Soedjatmiko, Medise, B. E., Gunardi, H., Yuniar, I., Indawati, W., Koesnoe, S., Harimurti, K., Maria, S., Wirahmadi, A., Sari, R. M., Setyaningsih, L., & Surachman, F.
(2024). Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in Indonesia. Vaccines, 12(4), 371.
https://doi.org/10.3390/vaccines12040371
